Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Exisulind may delay disease progression in prostate cancer patients

Oct. 10, 2001

Yamanouchi patents new series of antitumor agents

Oct. 9, 2001

Marine sponge-derived and synthetic antitumor compounds patented by Pharma Mar

Oct. 9, 2001

AMDL acquires combination immunogene therapy technology

Oct. 9, 2001

Genmab and Immunex to codevelop antibody therapeutics for lymphoma

Oct. 9, 2001

Pangene's DNA repair protein inhibitors reverse resistance in human cancers

Oct. 9, 2001

Recombinant molecule selected for clinical development as mucositis therapy by Alizyme

Oct. 8, 2001

Enrollment in phase II LDP-341 multiple myeloma trial completed ahead of schedule

Oct. 8, 2001

NeoPharm initiates phase I/II clinical trial for LEM in cancer

Oct. 8, 2001

Folate-based thymidylate synthase inhibitor CW-252053 safe and effective in tumor-bearing mice

Oct. 8, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...